{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T18:46:16Z","timestamp":1782413176964,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Pituitary apoplexy can be managed by early surgery or a conservative approach, if necessary, followed by later elective surgery. Choice of management is related to correct diagnosis, symptom severity at presentation and symptom development prior to contacting the pituitary center of excellence (PTCOE). Specific circumstances may dictate a specific choice, in others shared decision-making is key. This retrospective cohort study aimed to describe clinical decision-making and outcomes of pituitary apoplexy treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Outcome measures were factors relevant to treatment choice, visual acuity (VA), visual field defects (VFD), cranial nerve palsies, pituitary function, measured at three time points (baseline, 6 months after diagnosis, last follow-up).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We studied 98 patients with clinical apoplexy diagnosed between 2005 and 2021. After the first clinical evaluation, 45 patients underwent early surgery and 53 initial conservative management. Main indications for early surgery were lowered VA and\/or severe VFD. Postoperatively, mean VA improved from 0.63 (SD\u2009=\u20090.36) to 1.03 (SD\u2009=\u20090.3). VFD improved in 72.2% of patients. During continued follow-up, 21 initially conservatively treated patients had later elective surgery. VFD improved in 85.7% of these patients. Mean follow-up was &gt;\u200938 months for each group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The choice for surgery is mainly driven by ophthalmological symptoms, in which severity determines its timing. Although ophthalmological recovery rates are reasonable, (endocrine) outcomes of apoplexy are unfavorable, irrespective of trajectory. Prospective studies are needed to assess optimal (timing of) treatment, in particular in those patients without an obvious reason for early surgery, taking into account the heterogeneity and variable course of this condition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11102-026-01695-5","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:14:04Z","timestamp":1780064044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management-specific outcome evaluation of pituitary apoplexy; conservative and surgical approach"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9958-8590","authenticated-orcid":false,"given":"M. C.","family":"Guijt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.T.","family":"Verstegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. H.","family":"Zamanipoor Najafabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. E.H.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. C.","family":"Notting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. C.M.","family":"Pelsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. R.","family":"van Furth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. R.","family":"Biermasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. M.J.A.","family":"Claessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"3","key":"1695_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1590\/2359-3997000000047","volume":"59","author":"A Glezer","year":"2015","unstructured":"Glezer A, Bronstein MD (2015) Pituitary apoplexy: pathophysiology, diagnosis and management. Arch Endocrinol Metab 59(3):259\u2013264","journal-title":"Arch Endocrinol Metab"},{"key":"1695_CR2","doi-asserted-by":"publisher","first-page":"e988","DOI":"10.1016\/j.wneu.2019.07.055","volume":"130","author":"JP Almeida","year":"2019","unstructured":"Almeida JP, Sanchez MM, Karekezi C, Warsi N, Fern\u00e1ndez-Gajardo R, Panwar J et al (2019) Pituitary Apoplexy: Results of Surgical and Conservative Management Clinical Series and Review of the Literature. World Neurosurg 130:e988\u2013e99","journal-title":"World Neurosurg"},{"issue":"Supplement","key":"1695_CR3","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.4103\/0028-3886.287669","volume":"68","author":"N Muthukumar","year":"2020","unstructured":"Muthukumar N (2020) Pituitary Apoplexy: A Comprehensive Review. Neurol India 68(Supplement):S72\u2013s8","journal-title":"Neurol India"},{"key":"1695_CR4","doi-asserted-by":"publisher","first-page":"7951536","DOI":"10.1155\/2016\/7951536","volume":"2016","author":"A Albani","year":"2016","unstructured":"Albani A, Ferra\u00f9 F, Angileri FF, Esposito F, Granata F, Ferreri F et al (2016) Multidisciplinary Management of Pituitary Apoplexy. Int J Endocrinol 2016:7951536","journal-title":"Int J Endocrinol"},{"key":"1695_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s41016-020-00202-4","volume":"6","author":"Y Li","year":"2020","unstructured":"Li Y, Qian Y, Qiao Y, Chen X, Xu J, Zhang C et al (2020) Risk factors for the incidence of apoplexy in pituitary adenoma: a single-center study from southwestern China. Chin Neurosurg J 6:20","journal-title":"Chin Neurosurg J"},{"key":"1695_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.wneu.2019.08.115","volume":"132","author":"K Goshtasbi","year":"2019","unstructured":"Goshtasbi K, Abiri A, Sahyouni R, Mahboubi H, Raefsky S, Kuan EC et al (2019) Visual and Endocrine Recovery Following Conservative and Surgical Treatment of Pituitary Apoplexy: A Meta-Analysis. World Neurosurg 132:33\u201340","journal-title":"World Neurosurg"},{"issue":"2","key":"1695_CR7","doi-asserted-by":"publisher","first-page":"R49","DOI":"10.1093\/ejendo\/lvag034","volume":"194","author":"B Biagetti","year":"2026","unstructured":"Biagetti B, Marques P, Ntali G, Tsermoulas G, Karavitaki N, Sarria-Estrada S et al (2026) Management of endocrine disease: update on the management of pituitary apoplexy. Eur J Endocrinol 194(2):R49\u2013r66","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1695_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1530\/EC-20-0545","volume":"10","author":"F Iqbal","year":"2021","unstructured":"Iqbal F, Adams W, Dimitropoulos I, Muquit S, Flanagan D (2021) Pituitary haemorrhage and infarction: the spectrum of disease. Endocr Connect 10(2):171\u2013179","journal-title":"Endocr Connect"},{"key":"1695_CR9","doi-asserted-by":"crossref","unstructured":"Guijt MC, Zamanipoor Najafabadi AH, Notting IC, Pereira AM, Verstegen MJT, Biermasz NR et al (2022) Towards a pituitary apoplexy classification based on clinical presentation and patient journey. Endocrine","DOI":"10.1530\/endoabs.81.P172"},{"key":"1695_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4103\/2152-7806.199557","volume":"8","author":"A Abdulbaki","year":"2017","unstructured":"Abdulbaki A, Kanaan I (2017) The impact of surgical timing on visual outcome in pituitary apoplexy: Literature review and case illustration. Surg Neurol Int 8:16","journal-title":"Surg Neurol Int"},{"issue":"1","key":"1695_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.surneu.2004.03.014","volume":"63","author":"D Agrawal","year":"2005","unstructured":"Agrawal D, Mahapatra AK (2005) Visual outcome of blind eyes in pituitary apoplexy after transsphenoidal surgery: a series of 14 eyes. Surg Neurol 63(1):42\u201346 discussion 6","journal-title":"Surg Neurol"},{"issue":"3","key":"1695_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3340\/jkns.2010.48.3.213","volume":"48","author":"HJ Woo","year":"2010","unstructured":"Woo HJ, Hwang JH, Hwang SK, Park YM (2010) Clinical outcome of cranial neuropathy in patients with pituitary apoplexy. J Korean Neurosurg Soc 48(3):213\u2013218","journal-title":"J Korean Neurosurg Soc"},{"key":"1695_CR13","doi-asserted-by":"publisher","first-page":"106991","DOI":"10.1016\/j.clineuro.2021.106991","volume":"210","author":"B Cabuk","year":"2021","unstructured":"Cabuk B, Kaya NS, Polat C, Geyik AM, Icli D, Anik I et al (2021) Outcome in pituitary apoplexy patients, stratified by delay between symptom appearance and surgery: A single center retrospective analysis. Clin Neurol Neurosurg 210:106991","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"1695_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2265.2010.03913.x","volume":"74","author":"S Rajasekaran","year":"2011","unstructured":"Rajasekaran S, Vanderpump M, Baldeweg S, Drake W, Reddy N, Lanyon M et al (2011) UK guidelines for the management of pituitary apoplexy. Clin Endocrinol (Oxf) 74(1):9\u201320","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1695_CR15","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1365-2265.2004.02162.x","volume":"61","author":"J Ayuk","year":"2004","unstructured":"Ayuk J, McGregor EJ, Mitchell RD, Gittoes NJ (2004) Acute management of pituitary apoplexy\u2013surgery or conservative management? Clin Endocrinol (Oxf) 61(6):747\u2013752","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"1695_CR16","doi-asserted-by":"publisher","first-page":"e711","DOI":"10.1210\/clinem\/dgad541","volume":"109","author":"AN Mamelak","year":"2024","unstructured":"Mamelak AN, Little AS, Gardner PA, Almeida JP, Recinos P, Soni P et al (2024) A Prospective, Multicenter, Observational Study of Surgical vs Nonsurgical Management for Pituitary Apoplexy. J Clin Endocrinol Metab 109(2):e711\u2013e25","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1695_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ecl.2020.05.011","volume":"49","author":"WR van Furth","year":"2020","unstructured":"van Furth WR, de Vries F, Lobatto DJ, Kleijwegt MC, Schutte PJ, Pereira AM et al (2020) Endoscopic Surgery for Pituitary Tumors. Endocrinol Metab Clin North Am 49(3):487\u2013503","journal-title":"Endocrinol Metab Clin North Am"},{"key":"1695_CR18","doi-asserted-by":"publisher","first-page":"e723","DOI":"10.1016\/j.wneu.2019.02.138","volume":"126","author":"A Hosmann","year":"2019","unstructured":"Hosmann A, Micko A, Frischer JM, Roetzer T, Vila G, Wolfsberger S et al (2019) Multiple Pituitary Apoplexy-Cavernous Sinus Invasion as Major Risk Factor for Recurrent Hemorrhage. World Neurosurg 126:e723\u2013e30","journal-title":"World Neurosurg"},{"issue":"6993","key":"1695_CR19","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1136\/bmj.310.6993.1481","volume":"310","author":"P McGraw","year":"1995","unstructured":"McGraw P, Winn B, Whitaker D (1995) Reliability of the Snellen chart. BMJ 310(6993):1481\u20131482","journal-title":"BMJ"},{"issue":"3","key":"1695_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1442-9071.2010.02246.x","volume":"38","author":"J Landers","year":"2010","unstructured":"Landers J, Sharma A, Goldberg I, Graham SL (2010) Comparison of visual field sensitivities between the Medmont automated perimeter and the Humphrey field analyser. Clin Exp Ophthalmol 38(3):273\u2013276","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"1695_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0161-6420(85)34065-4","volume":"92","author":"RW Beck","year":"1985","unstructured":"Beck RW, Bergstrom TJ, Lichter PR (1985) A clinical comparison of visual field testing with a new automated perimeter, the Humphrey Field Analyzer, and the Goldmann perimeter. Ophthalmology 92(1):77\u201382","journal-title":"Ophthalmology"},{"key":"1695_CR22","unstructured":"KT JY, Babic N, Hannoush ZC, Weiss RE (2000) Endocrine Testing Protocols: Hypothalamic Pituitary Adrenal Axis. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K et al (eds) Endotext. South Dartmouth (MA): MDText.com, Inc. Copyright \u00a9 2000\u20132021. MDText.com, Inc."},{"issue":"25","key":"1695_CR23","first-page":"437","volume":"107","author":"S Petersenn","year":"2010","unstructured":"Petersenn S, Quabbe HJ, Sch\u00f6fl C, Stalla GK, von Werder K, Buchfelder M (2010) The rational use of pituitary stimulation tests. Dtsch Arztebl Int 107(25):437\u2013443","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"1695_CR24","doi-asserted-by":"publisher","first-page":"e1811","DOI":"10.1210\/clinem\/dgae649","volume":"110","author":"B Biagetti","year":"2025","unstructured":"Biagetti B, Cordero Asanza E, P\u00e9rez-L\u00f3pez C, Araujo-Castro M, Camara R, Guerrero-P\u00e9rez F et al (2025) Pituitary Apoplexy: Comorbidities, Management, and Outcomes-A Spanish Observational Multicenter Study. J Clin Endocrinol Metab 110(6):e1811\u2013e20","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1695_CR25","doi-asserted-by":"publisher","first-page":"e0139088","DOI":"10.1371\/journal.pone.0139088","volume":"10","author":"X Zhu","year":"2015","unstructured":"Zhu X, Wang Y, Zhao X, Jiang C, Zhang Q, Jiang W et al (2015) Incidence of Pituitary Apoplexy and Its Risk Factors in Chinese People: A Database Study of Patients with Pituitary Adenoma. PLoS ONE 10(9):e0139088","journal-title":"PLoS ONE"},{"issue":"6","key":"1695_CR26","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jocn.2009.11.012","volume":"17","author":"ZH Liu","year":"2010","unstructured":"Liu ZH, Chang CN, Pai PC, Wei KC, Jung SM, Chen NY et al (2010) Clinical features and surgical outcome of clinical and subclinical pituitary apoplexy. J Clin Neurosci 17(6):694\u2013699","journal-title":"J Clin Neurosci"},{"issue":"1","key":"1695_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1530\/EJE-10-0651","volume":"164","author":"DL M\u00f6ller-Goede","year":"2011","unstructured":"M\u00f6ller-Goede DL, Br\u00e4ndle M, Landau K, Bernays RL, Schmid C (2011) Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome. Eur J Endocrinol 164(1):37\u201343","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"1695_CR28","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.62713\/aic.4091","volume":"96","author":"X Li","year":"2025","unstructured":"Li X, Zheng X, Jiang Z, Shao D, Li Y (2025) A Comparative Study on Clinical Features, Surgical Outcomes, and Postoperative Complications in Pituitary Apoplexy vs. Non-Apoplexy Patients. Ann Ital Chir 96(8):1011\u20131017","journal-title":"Ann Ital Chir"},{"issue":"5","key":"1695_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1055\/a-0640-2915","volume":"128","author":"A Lammert","year":"2020","unstructured":"Lammert A, Walter MS, Giordano FA, Al Zhgloul M, Kr\u00e4mer BK, Nittka S et al (2020) Neuro-Endocrine Recovery After Pituitary Apoplexy: Prolactin as a Predictive Factor. Exp Clin Endocrinol Diabetes 128(5):283\u2013289","journal-title":"Exp Clin Endocrinol Diabetes"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01695-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01695-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01695-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:49:13Z","timestamp":1782409753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-026-01695-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1695"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01695-5","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}